Balyasny Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,419
Closed -$1.04M 2265
2020
Q4
$1.04M Sell
14,419
-161,361
-92% -$8.45M 0.01% 1007
2020
Q3
$8.01M Buy
175,780
+161,817
+1,159% +$6.76M 0.06% 460
2020
Q2
$631K Sell
13,963
-83,611
-86% -$3.75M 0.01% 901
2020
Q1
$3.76M Buy
97,574
+90,575
+1,294% +$4.17M 0.04% 471
2019
Q4
$324K Sell
6,999
-1,693
-19% -$73.3K ﹤0.01% 1052
2019
Q3
$354K Sell
8,692
-47,875
-85% -$2.07M ﹤0.01% 998
2019
Q2
$2.72M Buy
+56,567
New +$2.97M 0.02% 788
2019
Q1
Sell
-5,137
Closed -$307K 1810
2018
Q4
$307K Buy
+5,137
New +$308K ﹤0.01% 1223
2013
Q4
Sell
-998,893
Closed -$9.9M 776
2013
Q3
$9.9M Buy
998,893
+188,663
+23% +$1.48M 0.13% 205
2013
Q2
$4.78M Buy
+810,230
New +$2.73M 0.08% 303

Other funds holding BEAT

Balyasny Asset Management's BEAT Position: Q1 2021 in Review

Balyasny Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 14,419 shares — an estimated $1.04M sold.

Balyasny Asset Management first reported a position in BEAT in Q2 2013 and held it in 10 quarters. The position peaked at $9.9M in Q3 2013. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Balyasny Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 14,419 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.04M.
  • Balyasny Asset Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 10 quarters.
  • Balyasny Asset Management's BioTelemetry, Inc. position peaked at $9.9M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Balyasny Asset Management's 13F filing for Q1 2021, filed 17 May 2021.